Literature DB >> 15886523

Identification and characterization of peroxisome proliferator response element in the mouse GLUT2 promoter.

Seung-Soon Im1, Jae-Woo Kim, Tae-Hyun Kim, Xian-Li Song, So-Youn Kim, Ha-il Kim, Yong-Ho Ahn.   

Abstract

In the present study, we show that the expression of type 2 glucose transporter isoform (GLUT2) could be regulated by PPAR-gamma in the liver. Rosiglitazone, PPAR-gamma agonist, activated the GLUT2 mRNA level in the primary cultured hepatocytes and Alexander cells, when these cells were transfected with PPAR-gamma/RXR-alpha. We have localized the peroxisome proliferator response element in the mouse GLUT2 promoter by serial deletion studies and site-directed mutagenesis. Chromatin immunoprecipitation assay using ob/ob mice also showed that PPAR-gamma rather than PPAR-alpha binds to the -197/-184 region of GLUT2 promoter. Taken together, liver GLUT2 may be a direct target of PPAR-gamma ligand contributing to glucose transport into liver in a condition when PAPR-gamma expression is increased as in type 2 diabetes or in severe obesity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15886523     DOI: 10.1038/emm.2005.14

Source DB:  PubMed          Journal:  Exp Mol Med        ISSN: 1226-3613            Impact factor:   8.718


  15 in total

1.  The role of peroxisome proliferator-activated receptor γ in pancreatic β cell function and survival: therapeutic implications for the treatment of type 2 diabetes mellitus.

Authors:  D Gupta; T Kono; C Evans-Molina
Journal:  Diabetes Obes Metab       Date:  2010-12       Impact factor: 6.577

2.  Curcumin diminishes the impacts of hyperglycemia on the activation of hepatic stellate cells by suppressing membrane translocation and gene expression of glucose transporter-2.

Authors:  Jianguo Lin; Anping Chen
Journal:  Mol Cell Endocrinol       Date:  2010-12-30       Impact factor: 4.102

3.  Peroxisome proliferator-activated receptor ligand MCC-555 suppresses intestinal polyps in ApcMin/+ mice via extracellular signal-regulated kinase and peroxisome proliferator-activated receptor-dependent pathways.

Authors:  Kiyoshi Yamaguchi; Maria Cekanova; Michael F McEntee; Joo-Heon Yoon; Susan M Fischer; Ingrid B Renes; Isabelle Van Seuningen; Seung Joon Baek
Journal:  Mol Cancer Ther       Date:  2008-09       Impact factor: 6.261

4.  Current Protocols in Mouse Biology.

Authors:  Casey R Doucette; Clifford J Rosen
Journal:  Curr Protoc Mouse Biol       Date:  2014

5.  Peroxisome proliferator-activated receptor gamma activation restores islet function in diabetic mice through reduction of endoplasmic reticulum stress and maintenance of euchromatin structure.

Authors:  Carmella Evans-Molina; Reiesha D Robbins; Tatsuyoshi Kono; Sarah A Tersey; George L Vestermark; Craig S Nunemaker; James C Garmey; Tye G Deering; Susanna R Keller; Bernhard Maier; Raghavendra G Mirmira
Journal:  Mol Cell Biol       Date:  2009-02-23       Impact factor: 4.272

Review 6.  Regulation of energy metabolism pathways by estrogens and estrogenic chemicals and potential implications in obesity associated with increased exposure to endocrine disruptors.

Authors:  Jin-Qiang Chen; Terry R Brown; Jose Russo
Journal:  Biochim Biophys Acta       Date:  2009-04-05

Review 7.  Peroxisome proliferator activated receptors at the crossroad of obesity, diabetes, and pancreatic cancer.

Authors:  Simone Polvani; Mirko Tarocchi; Sara Tempesti; Lapo Bencini; Andrea Galli
Journal:  World J Gastroenterol       Date:  2016-02-28       Impact factor: 5.742

8.  Interrelationship between liver X receptor alpha, sterol regulatory element-binding protein-1c, peroxisome proliferator-activated receptor gamma, and small heterodimer partner in the transcriptional regulation of glucokinase gene expression in liver.

Authors:  Tae-Hyun Kim; Hail Kim; Joo-Man Park; Seung-Soon Im; Jin-Sik Bae; Mi-Young Kim; Ho-Geun Yoon; Ji-Young Cha; Kyung-Sup Kim; Yong-Ho Ahn
Journal:  J Biol Chem       Date:  2009-04-14       Impact factor: 5.157

Review 9.  Transcriptional regulation of glucose sensors in pancreatic β-cells and liver: an update.

Authors:  Jin-Sik Bae; Tae-Hyun Kim; Mi-Young Kim; Joo-Man Park; Yong-Ho Ahn
Journal:  Sensors (Basel)       Date:  2010-05-19       Impact factor: 3.576

10.  Leucine alters hepatic glucose/lipid homeostasis via the myostatin-AMP-activated protein kinase pathway - potential implications for nonalcoholic fatty liver disease.

Authors:  Aida Zarfeshani; Sherry Ngo; Allan M Sheppard
Journal:  Clin Epigenetics       Date:  2014-11-18       Impact factor: 6.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.